Budd-Chiari syndrome: Difference between revisions
(Text replacement - "* " to "*") Tag: mobile edit |
ClaireLewis (talk | contribs) No edit summary |
||
| Line 10: | Line 10: | ||
==Evaluation== | ==Evaluation== | ||
*[[LFTs]], BMP, LDH | *[[LFTs]], BMP, LDH | ||
*Ultrasound, retrograde angiography | *[[RUQ ultrasound|Ultrasound]], retrograde angiography | ||
*CT and MRI less sensitive | *CT and MRI less sensitive | ||
==Management== | ==Management== | ||
*Sodium restriction, [[diuretics]], [[anticoagulants]] | *Sodium restriction, [[diuretics]], [[anticoagulants]] | ||
* | *Venous shunts or TIPS | ||
* | *Liver transplant | ||
==Disposition== | ==Disposition== | ||
Revision as of 19:45, 29 September 2019
Background
- Rare
- Caused by occlusion of hepatic veins, 75% primary (thrombosis), 25% secondary (compression by mass)
- Fulminant, acute, chronic, or asymptomatic.
Clinical Features
- Classic triad: abdominal pain, ascites, and hepatomegaly
Differential Diagnosis
Evaluation
- LFTs, BMP, LDH
- Ultrasound, retrograde angiography
- CT and MRI less sensitive
Management
- Sodium restriction, diuretics, anticoagulants
- Venous shunts or TIPS
- Liver transplant